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ABSTRACT
Objective UNAIDS and country analysts use a simple
infectious disease model, embedded in the Estimation
and Projection Package (EPP), to generate annual
updates on the global HIV/AIDS epidemic. Our objective
was to develop modiﬁcations to the current model that
improve ﬁt to recently observed prevalence trends
across countries.
Methods Our proposed alternative to the current EPP
approach simpliﬁes the model structure and explicitly
models changes in average infection risk over time,
operationalised using penalised B-splines in a Bayesian
framework. We also present an alternative approach to
initiating the epidemic that improves standardisation and
efﬁciency, and add an informative prior distribution for
changes in infection risk beyond the last data point that
enhances the plausibility of short-term extrapolations.
Results The spline-based model produces better ﬁts
than the current model to observed prevalence trends in
settings that have recently experienced levelling or rising
prevalence following a steep decline, such as Uganda
and urban Rwanda. The model also predicts
a deceleration of the decline in prevalence for countries
with recent experience of steady declines, such as
Kenya and Zimbabwe. Estimates and projections from
our alternative model are comparable to those from the
current model where the latter performs well.
Conclusions A more ﬂexible epidemiological model that
accommodates changing infection risk over time can
provide better estimates and short-term projections of
HIV/AIDS incidence, prevalence and mortality than the
current EPP model. The alternative model speciﬁcation
can be incorporated easily into existing analytical tools
that are used to produce updates on the global HIV/AIDS
epidemic.
INTRODUCTION
Many countries lack sufﬁcient health information
systems to measure the number of individuals
living with HIV/AIDS, the rate of new infections,
and the need for antiretroviral therapy (ART). To
ﬁll this information gap, the UNAIDS Reference
Group on Estimates, Modelling and Projections
developed, and continues to reﬁne, an epidemio-
logical model for estimation and short-term
extrapolation of HIV/AIDS trends from limited
surveillance data.
1e5 The model (referred to here-
after as the ‘Reference Group model’) is imple-
mented in the freely available Estimation and
Projection Package (EPP) and is used by UNAIDS
and analysts in countries to generate annual
updates on the global HIV/AIDS epidemic.
56
While the Reference Group model provides
a relatively simple tool that produces plausible ﬁts
to a wide variety of observed patterns in surveil-
lance data, a number of speciﬁc patterns have been
challenging to reproduce. Examples include coun-
tries in which observed prevalence has declined
sharply and then levelled off, and countries in
which prevalence has been steadily increasing or
decreasing.
5 Other concerns have been noted
regarding short-term projections of prevalence
approaching zero in several settings, which are
regarded as epidemiologically implausible.
5 These
limitations of the model stem in part from its
approach to approximating changes in infection
risk over time,
7 which may result from the spread
of an epidemic in a population with heterogeneous
risk behaviour, or from changes in individuals’
sexual behaviour.
89
The rapid rise in prevalence in the early years of
many African epidemics is consistent with a high
initial force of infection on average, as the epidemic
begins to spread among a population with
relatively high-risk behaviours. However, if this
high average infection rate were to persist as HIV
expanded into the general population, prevalence
would reach unrealistically high levels. To address
this dynamic, the Reference Group model parti-
tions the uninfected population into two risk
groups, ‘susceptible, not at-risk’ and ‘susceptible,
at-risk’. The fraction of the population initially in
the ‘susceptible, at-risk’ compartment constrains
the peak prevalence level. The rate at which
prevalence declines after its peak is determined by
the balance between new infections and mortality,
and can be modulated in the Reference Group
model to a limited degree by adjusting the fraction
of new adults entering the ‘susceptible, at-risk’
population.
2 Overall, the Reference Group model
speciﬁcation is well suited to characterising various
patterns of prevalence during the early phase of an
epidemic and in the time shortly after a peak, but
the model is less ﬂexible in accommodating
different types of trajectories as epidemics move
further in time beyond peak prevalence.
Modiﬁcations to the Reference Group model that
enable better ﬁts to prevalence data should meet
several criteria. First, a modiﬁed model should
maintain the explicit connection in the current
model between prevalence of infected people and
the risk of infection among uninfected people.
Models that ﬁt curves directly to prevalence data
without explicitly modelling the underlying infec-
tion dynamics might, for example, produce a prev-
alence curve that would imply a negative incidence
1Harvard School of Public
Health, Center for Health
Decision Science, Boston,
Massachusetts, USA
2Harvard University, Centre for
Risk Analysis, Boston,
Massachusetts, USA and
Toulouse School of Economics
(LERNA-INRA), Toulouse,
France
3Harvard University, Center for
Risk Analysis, Boston,
Massachusetts, USA
4Harvard School of Public
Health, Department of Global
Health and Population, Boston,
Massachusetts, USA
Correspondence to
Daniel R Hogan, Harvard School
of Public Health, Center for
Health Decision Science, 718
Huntington Ave 2nd Floor,
Boston, MA 02115, USA;
dhogan@fas.harvard.edu
Accepted 8 September 2010
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://sti.
bmj.com/site/about/unlocked.
xhtml
ii84 Sex Transm Infect 2010;86(Suppl 2):ii84eii92. doi:10.1136/sti.2010.045104
Supplementrate. Another argument for maintaining an explicit epidemio-
logical model (as opposed to a curve-ﬁtting approach) is to
accommodate estimation of incidence and mortality patterns,
scenario analyses and future predictions. Second, parsimony is
important as many settings do not have the data required to
parameterise more complex models, such as those that incor-
porate age structure, detailed patterns of sexual behaviour, or
expanded risk group structure.
10e12 Simpler models also require
less computational power, which is an important consideration
for end-users of EPP. Finally, a modiﬁed model for EPP should be
ﬂexible enough to ﬁt a variety of epidemic trajectories around
the world.
Previously, we suggested a relatively parsimonious modiﬁca-
tion to the Reference Group model that would eliminate the
current partitioning of the susceptible population into ‘at-risk’
and ‘not-at-risk’ segments, but would allow the average
infection rate to change over time.
7 From an epidemiological
standpoint, such an approach should respect the weak
constraint that changes in the infection rate should be relatively
smooth over the course of the epidemic. In this paper, we
present a speciﬁc operationalisation of this alternative approach
using penalised B-splines to model the annual infection rate
parameter as a function of time. Our proposed model adds two
further modiﬁcations to the current model, which provide (1)
a more standardised and efﬁcient way to model the initial phase
of an epidemic, and (2) improved plausibility of extrapolations
beyond the last observed data point by incorporating an
informative prior distribution for short-term projections of
infection risks.
METHODS
Data sources
For many generalised epidemics, such as those in sub-Saharan
Africa, the primary source of time series data on HIV prevalence
is a system of sentinel surveillance sites that undertake
anonymous HIV-prevalence testing of blood samples from
pregnant women attending antenatal clinics (ANC).
13 Use of
ANC data has been justiﬁed based on the argument that prev-
alence among pregnant women serves as a reasonable proxy for
prevalence in the general adult population, although some
concerns have been noted about the representativeness of the
sample and the possible effects of changing rates of
contraceptive use over time.
14 15 More recently, results from
national population-based surveys have indicated that ANC data
tend to overestimate prevalence in the general population.
16
Since these surveys are only available for 1 or 2 years in most
countries, the Reference Group model uses ANC data to inform
the shape of prevalence over time and calibrates this curve to
match the level of the national population-based survey
estimates when available.
5 As we are primarily concerned in
the present study with characterising the shape of prevalence
curves generated under alternative models, we omit this
calibration step here in order to facilitate visual inspection of
model output in relation to empirical ANC data. Our approach,
however, generalises easily to a more detailed overall modelling
approach that includes calibration to estimates from national
surveys.
We ﬁt the model separately to a total of 18 populations,
distinguishing urban from rural regions in nine countries:
Angola, Burundi, Ethiopia, Gabon, Kenya, Lesotho, Rwanda,
Uganda and Zimbabwe. Rwanda and Uganda offer two impor-
tant examples in which the Reference Group model fails to
capture recent trends in prevalence.
Proposed model
Our proposed alternative to the current EPP model explicitly
represents changes in infection risks over time to better
approximate patterns of HIV spread in generalised epidemics.
We simplify the population structure of the Reference Group
model by collapsing the ‘susceptible, at-risk’ and ‘susceptible,
not at-risk’ compartments into one uninfected (and at-risk) sub-
population. In line with the modiﬁed structure, we remove two
corresponding parameters from the Reference Group model d
f0, which governs the initial split between at-risk and not-at-risk
entrants, and f, which modulates this split in mature epidemics.
In assessing the performance of the spline-based approach, we
limit our analysis to scenarios that do not include ART, although
we note again that our approach generalises easily to a more
detailed speciﬁcation including ART.
The model can be described by three differential equations,
following the general notation for the Reference Group model
used in EPP 2009
17:
dY=dt ¼ VðtÞ 
Z t
0
VðxÞ$g1ðt xÞdx mYðtÞ
dU=dt ¼
Z t
0
VðxÞ$g1ðt xÞdx 
Z t
0
UðxÞ$g2ðt xÞdx mUðtÞ
dZ=dt ¼ EðtÞ VðtÞ mZðtÞ
where
VðtÞ¼rðtÞ$ðYðtÞþUðtÞÞ$ZðtÞ=NðtÞ
The key difference in the parameterisation of this model
compared with that in the current Reference Group model is the
use of a time-varying function for infection risks, r(t), modelled
using splines, rather than assuming constant r. A number of
other key elements of the model are consistent with the current
Reference Group formulation. The model distinguishes early-
stage from late-stage infection (eg, those having CD4 counts
above or below 200 cells/ml) in order to accommodate the
modelling of treatment eligibility. Y represents the number of
HIV-positive individuals at the earlier stage, U is the number of
HIV-positive individuals at the later stage, and Z is the number
of uninfected individuals (Y+U+Z¼N). E(t) is the number of
new adults entering the population at time t and is a function of
HIV prevalence 15 years earlier, which accounts for differential
fertility and child survival by maternal HIV status. The func-
tions g1(x) and g2(x) determine HIV disease progression, from the
early to the more advanced stage, and from the advanced stage
to AIDS-related death, respectively. Both functions are para-
meterised as Weibull densities, with shape and location param-
eters a¼1.69 and b¼10.40 for g1(x) and a¼1.00 and b¼2.52 for
g2(x), yielding median residence times of 8.4 and 1.8 years,
respectively.
We make another important modiﬁcation to the Reference
Group model by changing the way in which the model captures
the initial phase of an epidemic. Fitting the Reference Group
model currently requires estimation of the year (t0) in which
a ﬁxed seed value of Yt0¼0.0025 initiates the epidemic. In our
proposed speciﬁcation, an epidemic is initiated in 1975 with
a small pulse of infected individuals Y0, which is a parameter to
be estimated with a broad prior uniform distribution spanning
the range 10
-13 to 0.0025. Given the large uncertainty about
when HIV ﬁrst appeared in human populations,
18 and the
inevitable artiﬁce of simulating the introduction and initial
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Supplementspread of HIV as a discrete event, this new approach avoids
having to estimate the ‘start year’ of the epidemic, while
acknowledging substantial uncertainty about the early dissem-
ination of HIV through the population. It also ensures
a constant number and position of splines for the r function and
improves efﬁciency, as the ﬁtting algorithm no longer needs to
be re-run for each potential value of t0.
There are several possible choices of spline functions for
modelling infection risks over time, r(t).
19 20 We propose to use
third degree B-splines with a difference penalty to enforce
smoothness (also referred to as ‘P-splines’).
21 B-splines are easy
to generate (the basis functions consist of polynomial pieces)
and have stable boundaries. With this formulation, a relatively
large number of basis functions can be set at equal intervals, and
a difference penalty on the coefﬁcients of adjacent basis
functions determines the amount of smoothing.
21 Here we use
a second-degree difference penalty, which enforces smoothness
in the second derivative of the spline function (ie, smooth
changes in the slope of r over time in the epidemic model).
Figure 1 shows an example of how one trajectory for r(t) (thick
solid line) is generated from seven B-spline basis functions
(dotted lines), as used in our analysis. The function r(t)i s
constructed as a linear combination of the basis functions, with
the spline coefﬁcients (denoted b1 through b7) serving as
weights.
In line with the current strategy for estimating model
parameters and characterising uncertainty, we adopt a Bayesian
approach to ﬁtting the model to surveillance data,
22 speciﬁcally
using a Bayesian analogue to B-splines with difference penal-
ties.
23 For the second-degree difference penalty used here, the
coefﬁcient for basis function i is expected to follow the trend of
the previous two coefﬁcients, and its prior can be expressed as:
bi¼bi- 1+(bi- 1ebi- 2)+ui. The priors for b1 and b2 are assumed to
be proportional to a constant. Note that if all of the b coefﬁ-
cients are equal, the resulting ‘curve’ will be a horizontal line. On
the other hand, if a spline coefﬁcient differs greatly from its
neighbouring coefﬁcients, we expect the curve to change in
value rather quickly over the range of that basis function. By
letting ui w normal(0,s
2), the amount of smoothness is deter-
mined by the variance parameter s
2, as smaller values for s
2 will
produce smaller values for ui, which in turn imply a smoother
function. The parameter s
2 is estimated during model ﬁtting,
and we use the common uninformative prior s
2 w inverse-
gamma(0.001,0.001).
24 In preliminary analyses we tested
between four and 10 evenly-spaced basis functions and found
that seven basis functions were sufﬁcient to obtain adequate
ﬂexibility for r(t) to match a wide variety of different empirical
prevalence trends. When ﬁtting the model, we add a further
constraint that r must always be positive.
Short-term projections
While the primary objective of the model described here is to
estimate past epidemic trends for reporting on the current status
of HIV/AIDS epidemics, one of the required functions of the
model is to make short-term projections beyond the last
observed data point in settings that lack data for the most recent
reporting year(s). There are a range of methodological challenges
in extrapolating time series beyond the last observed data point,
including both general challenges and certain challenges speciﬁc
to spline models.
25 26 In order to address the challenge of
extrapolation, we incorporate a prior probability distribution for
future values of r derived from observed prevalence levels in the
most recent years of data. The speciﬁcation of the prior draws
on the mathematical theory of infectious disease dynamics.
27
Brieﬂy, if we let I be the proportion infected and S be the
proportion uninfected, with infection rate r and mortality rate m,
the change in the infected population is given by dI/dt¼rISemI.
At later stages in an epidemic, we expect prevalence to approach
equilibrium, all else being equal. Under this formulation, dI/dt¼0
when r¼m/S, which we approximate as rz1/(1e prevalence)3
1/duration. (This is an approximation given a non-constant
mortality rate for HIV/AIDS.) With the mortality assumptions
in EPP 2009, mean duration with HIV/AIDS is approximately
11.5 years. We implement this prior for r(t) by assuming that
future values of r are normally distributed, with mean r(t)¼1/
(1eY(t
*)/N(t
*))31/11.5, where Y(t
*)/N(t
*) is modelled preva-
lence in the last year of data. Variance of the distribution is set
equal to the mean of the squared deviations between r(t) and 1/
(1eY(t)/N(t))31/11.5 for the last 10 data-supported years of the
projection. The prior is included in the model ﬁtting process and
serves to guide the spline curve (which is generated as a contin-
uous function for the entire estimation and projection period)
beyond the last observed data point.
We note that this prior is intended only to ensure that most
curves for r reside within a reasonable range for later-stage, fully
generalised epidemics, and not necessarily to capture long-term
dynamics in future predictions. By ‘reasonable range’,w e
suggest, for example, that an annual value of r¼1, which implies
an average of more than 11 secondary infections over the life-
time of an infected person, would be unreasonably high for
a late-stage epidemic as illustrated by Uganda in 2010, given that
the average lifetime number of sexual partners has been esti-
mated at around 2e3 for women and 10 for men across several
African studies,
28 and that most partnerships do not result in
infection (the average probability of transmission in a single
sexual act has been estimated to be as low as 1 per 1000).
29 A
recent modelling study based on long-term follow-up of a cohort
in Rakai, Uganda estimated that approximately two new
infections would be generated by each infected individual based
on random mixing in sexual partnerships,
30 which underscores
that values for r should be much less than 1 and within the
range implied by the prior used here for future values of r.
Model ﬁtting
Following the work of Bao and Raftery, we use incremental
mixture importance sampling (IMIS) for model ﬁtting, which is
Figure 1 Example of a spline-based curve for infection risks over time
(solid line) using third degree B-splines comprised of seven evenly-
spaced basis functions (dashed curves labelled 1 through 7). The spline
curve is a linear combination of the basis functions and their coefﬁcients
(labelled b1 through b7).
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Supplementa Bayesian algorithm for simulating posterior distributions.
31 We
employ the same likelihood as that used currently in EPP, which
assumes that prevalence is normally distributed on the probit
scale, with random effects for ANC sites.
32 The spline-based
model was programmed in the software package R, with some
functions written in C to increase computational speed, and the
model differential equations were approximated as difference
equations in quarter-year increments. For comparison with the
existing Reference Group model, results were obtained by
running the uncertainty analysis option in EPP 2009. For the
spline-based model, we added the additional constraints that r
<20 and prevalence <95% to increase the efﬁciency of the IMIS
algorithm. These constraints allowed us to avoid calculating the
likelihood for proposed parameter sets that led to epidemiolog-
ically implausible epidemic trajectories. The choice of r <20 was
a very weak constraint; we did not observe values of 10 or
greater in the posterior distributions of r for any country. We
started the IMIS algorithm with 900000 initial draws, with 900
draws for each importance sampling iteration.
Model evaluation
We compared the alternative models in terms of their observed
ﬁt to surveillance data from all sites. The performance of the
models was also evaluated based on more formal criteria. To
compare the relative ﬁt of the spline-based and Reference Group
models to ANC data, we computed Bayes factors
33 along with
Figure 2 Median prevalence with 95% credible intervals (in black) for the spline-based model for r, with the best ﬁt from the EPP 2009 Reference
Group model added for comparison (in blue) for nine selected settings. Observed prevalence data for antenatal clinic sites to which the models are ﬁt
are plotted in various colours.
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Supplementdensity plots of the marginal likelihoods for both models. We
further evaluated the spline-based model with posterior predic-
tive checks of in-sample ﬁt by comparing posterior predicted
prevalence to observed prevalence for each site-year observation.
We performed these posterior predictive checks after
constructing case-deleted posteriors for each ANC site’s random
effect via sample reweighting,
34 and we obtained predicted
random effects for ANC prevalence via rejection sampling.
32 To
assess the model’s performance in out-of-sample projection, we
truncated the last 3 years of data, re-ﬁt the model and deter-
mined if the 95% credible intervals for prevalence covered the
median projection from the model ﬁt to the full ANC time
series. We tested the robustness of the IMIS algorithm by re-
running our standard projections with a different random seed
and comparing the posteriors for r, incidence and prevalence. We
also investigated the sensitivity of the results to the prior on s
2,
and we visually compared posterior distributions of each model
parameter to the distribution of initial draws for the IMIS
algorithm.
RESULTS
As shown by the illustrative examples in ﬁgure 2, the spline-
based model appears to out-perform the Reference Group model
in capturing trends in prevalence in countries that have recently
experienced a levelling off or rise in prevalence following a steep
decline (see urban and rural Uganda, urban Rwanda and rural
Burundi). The spline-based model also predicts a deceleration of
Figure 3 Posterior predicted prevalence versus observed prevalence across all antenatal clinic sites for urban and rural Uganda, along with posterior
predicted site-level prevalence for four selected antenatal clinics (red indicates observed site prevalence, black indicates median and 95% prediction
intervals for predicted site prevalence).
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Supplementthe decline in prevalence for countries that have recently expe-
rienced steady declines, such as Kenya and Zimbabwe. Bayes
factors indicate that the spline-based model produces a better ﬁt
to ANC data than the original Reference Group model for all 18
settings examined (all values for 2 log(BF)>7), including those
settings in which the Reference Group model produces
a reasonable visual ﬁt to the data.
Posterior predictive checks suggest that the spline-based
model predicts the observed data well across and within sites.
Figure 3 shows examples from Uganda. Predicted prevalence
across all ANCs was highly consistent with observed prevalence
overall, and site-level prediction intervals for prevalence typically
contained the observed values. Exceptions included some
instances in which the model over-predicted low-prevalence
values; however, we note that in these instances comparable
or greater errors were observed in the Reference Group model.
A small number of very high prevalence values were under-
predicted by both models.
The IMIS algorithm was largely insensitive to initial condi-
tions. In comparing posterior projections from the algorithm
started with two different random seeds, estimated values for r
during the early phase of the epidemic varied between simula-
tions for some countries. However, initial patterns of incidence
(and prevalence), which are determined by the combination of r
and the initial pulse of infection Y0, were much more similar,
and patterns of r converged by the time prevalence peaked. (The
IMIS algorithm clearly outperformed a Markov Chain Monte
Carlo sampler with respect to convergence.) Trajectories for r,
incidence, and prevalence from a model which assumed s
2 w
uniform(0,30) were similar to the s
2 w inverse-gamma
(0.001,0.001) prior model, with some differences in early-stage
estimates for urban Burundi and rural Rwanda.
The model we propose here incorporates an informative
Bayesian prior probability distribution for projections of r
beyond the last observed data point. We evaluated this model-
ling choice in two ways. First, we examined whether including
the prior alters in-sample estimates compared with a model
without a prior. Across the 18 settings included in our analysis,
the prior had little discernible impact on in-sample ﬁt, particu-
larly after the peak in prevalence (ﬁgure 4). Second, we tested
the model’s ability to extrapolate beyond the last observed data
point (ie, to predict out-of-sample) by deleting the last 3 years of
observed data for each setting, and then reﬁtting the model to
determine if the uncertainty bounds for the out-of-sample
predictions contained the original data-supported median
predictions. Performance of out-of-sample predictions was
strongest where several years of observed data were available
after the epidemic peak (ﬁgure 5). Out-of-sample prediction
errors were largest in settings with relatively sparse data, or
settings in which the last data points occurred around the time
that prevalence was peaking (as in Gabon). The model also failed
to predict the exceptional, sudden reversal observed in rural
Uganda. In this latter case, given a point of inﬂection coinciding
almost precisely with the truncation of the data, we expect that
out-of-sample predictions from any model would likely suffer
from similar imperfections. For 3-year out-of-sample predictions,
the median full data prediction fell within the 95% credible
intervals for 12 out of 18 settings.
As rising coverage of ART makes interpretation of trends in
prevalence increasingly complicated, there has been a corre-
sponding shift in emphasis towards measurement and modelling
of incidence. This shift is reﬂected in the most recent changes to
the suite of tools used by UNAIDS and country analysts in their
routine updates on the status of HIV/AIDS epidemics.
17 In light
Figure 4 Median prevalence with 95% credible intervals for the spline-based model with (in black) and without (in blue) a prior for the future
behaviour of r for six selected settings. Observed prevalence data for antenatal clinic sites to which the models are ﬁt are plotted in various colours.
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Supplementof this shift in emphasis, it is critically important that evalua-
tion of alternative models includes assessment of estimated
trends in r, incidence and mortality as well as trends in preva-
lence. As shown in ﬁgure 6 for urban Uganda and urban
Rwanda, incidence may be increasing even in the presence of
declining prevalence. The general pattern of r shown in ﬁgure 6,
with r starting at a high value and then falling to lower levels, is
common across the 18 settings included in this study and is
consistent with our understanding of how the force of infection
should change as an epidemic becomes generalised. The pattern
for r over the last 5 years of the projection was more variable
across countries, which underscores recent concerns about
potential reversals in progress on preventing risky behaviours in
some settings.
DISCUSSION
Our investigation into relaxing the UNAIDS Reference Group
model’s assumption of a constant infection rate parameter over
time suggests that it is feasible to obtain better ﬁts to recent
prevalence data, as evidenced by the ﬂexible model’s ability to
Figure 5 Median prevalence with 95%
credible intervals for out-of-sample
prevalence predictions for the spline-
based model (in blue), with median ﬁt
for the full-sample results added for
comparison (in black), for four selected
settings. Data for the last 3 years of
observation were excluded for
generating out-of-sample predictions
(denoted by the vertical dashed line).
Figure 6 Plots of r, incidence and
mortality for urban Uganda and urban
Rwanda from the spline-based model.
Unique curves from the posterior are
plotted in grey, along with the median
and 95% credible intervals.
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Supplementcapture recent trends in Uganda and Rwanda. The model also
shows promise in avoiding projected prevalence declining
towards zero for epidemics like that in Kenya. Using splines to
model r as a function of time directly addresses changing
infection risk while respecting basic epidemiological constraints
and maintaining smooth patterns of r, incidence, mortality and
prevalence.
Several limitations in the proposed model should be noted.
The spline-based approach in the formulation presented here
yielded divergent out-of-sample predictions in some countries. It
is worth noting, however, that the out-of-sample prediction
errors typically occurred in settings where predictions were
made in close proximity to an epidemic peak. For the intended
use of this model, most generalised epidemics have advanced
sufﬁciently beyond the peak that the required out-of-sample
predictions should be less vulnerable to error. The choice of prior
for r to enable short-term future predictions also has limitations.
First, it assumes that an epidemic is trending towards equilib-
rium. Second, it assumes a constant mortality rate, which is an
approximation of a more complicated pattern of survivorship,
and the inclusion of disease-induced mortality can alter the
equilibrium dynamics of epidemic models.
35 Further examina-
tion of alternative speciﬁcations for the Bayesian prior on r
might reveal better options.
An important limitation in both the ﬂexible model and the
Reference Group model is that they focus on average rates of
infection and mortality across the entire adult population, thus
summarising the dynamics of HIV spread through a heteroge-
neous population with a few equations instead of explicitly
modelling the distribution of risk behaviours across individuals
and accounting for the age structure of the population.
10e12 Our
proposed approach has some advantages in this regard compared
with the current model. Allowing r to change over time
approximates the dynamics associated with HIV spreading into
the general population as an epidemic progresses, while still
maintaining the parsimonious framework of the Reference
Group model. The spline-based approach also generates smooth
patterns of incidence and mortality, unlike a pragmatic approach
to increasing the ﬂexibility of the Reference Group model that
allows for a shift in the proportion of new adults recruited to the
at-risk population.
17
In comparison to the Reference Group model, the spline-based
approach imposes somewhat greater computational demands.
With seven spline basis functions there are a total of nine
parameters to estimate, compared with four in the Reference
Group model. On average the IMIS algorithm needed to calcu-
late twice as many likelihoods when ﬁtting the spline-based
model as when ﬁtting the Reference Group model. The relatively
common shape of r over time across countries suggests that
computation could be made more efﬁcient by centering the
initial draws for the IMIS algorithm on more plausible values.
The similarity in patterns of infection risk across countries also
suggests that hierarchical modelling of multiple epidemics could
improve estimates for countries with sparse data and may be
a fruitful area for future research. The incorporation of age
structure into a ﬂexible model for r is another potential area for
further study.
By obtaining better projections of HIV/AIDS epidemic
dynamics, a modiﬁcation to the Reference Group model that
allows r to vary over time has the potential to improve the
accuracy of estimates that are used by decision makers to track
the state of the epidemic and to plan future health resource
needs. Future research on ﬂexible modiﬁcations to the Reference
Group model should include a careful consideration of ART
provision, which not only affects survivorship but also trans-
mission rates for those receiving treatment. Both effects can be
accommodated with the model proposed here, and they will be
important for obtaining accurate estimates of incidence from
prevalence in the coming years, as increases in prevalence may be
due to decreases in mortality as well as new infections. Finally,
the performance of a ﬂexible function for r should be explored in
the context of countries with concentrated epidemics, which
may require stronger modelling assumptions to overcome the
difﬁculties in ﬁtting curves to distinct sub-epidemics with little
surveillance data.
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